The University of Pittsburgh Medical Center (UPMC) has developed a groundbreaking predictive model for metastatic uveal melanoma patients’ response to adoptive therapy, offering hope in treating this resistant cancer. Led by Dr. Udai Kammula,…
Continue Reading
By Shania Kennedy
April 08, 2024 – Machine learning tools can accurately forecast an unplanned hospitalization event during concurrent chemoradiotherapy (CRT) using patient-generated health data from wearable devices, according to a study published recently in JAMA…
Continue Reading
By Anuja Vaidya
March 29, 2024 – A telephone-based rehabilitation intervention improved participation in daily activities among breast cancer survivors but did not otherwise accelerate their recovery, according to a study published in JAMA Network Open.
Cancer…
Continue Reading
What You Should Know:
AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).The acquisition marks a major step forward in AstraZeneca delivering on its ambition to…
Continue Reading
Radformation and Icon Group have forged a transformative partnership to redefine cancer care through cutting-edge software solutions and streamlined workflows. This collaboration combines Radformation’s expertise in radiation oncology software with Icon Group’s global leadership…
Continue Reading
RaySearch Laboratories celebrates a pivotal milestone as RayStation, their cutting-edge treatment planning system, gains traction in over 1,000 radiotherapy centers worldwide. With a stronghold in the United States, Japan, and China, RayStation’s versatility supports…
Continue Reading
Welcome to the January edition of Digital Health Digest on our YouTube channel! Dive into the latest and most exciting advancements in digital healthcare, from cutting-edge diagnostic tools to innovative telehealth services. In this…
Continue Reading
What You Should Know:
– ArteraAI, a pioneer in multi-modal artificial intelligence (MMAI) for cancer treatment personalization, announced today an additional $20M in funding.
– This latest round, backed by prominent investors like Prosperity7 Ventures, EDBI,…
Continue Reading
What You Should Know: – PathAI, a pioneer in AI-powered pathology, announced a significant expansion of its PathExplore platform, adding six new oncology indications to its arsenal. – The expansion doubles the platform’s reach,…
Continue Reading
The Regional Cancer Centre in Kerala’s capital Thiruvananthapuram has reportedly received $7 million in funding to put up a robotic surgery facility, which is a first in a public hospital in India.Inaugurated this week, the…
Continue Reading
